Race and Ethnicity in Cancer Therapy: What Have We Learned?
Racial and ethnic disparities in the pathogenesis of common malignancies and outcomes from treatment remain a major health concern. Factors attributed to these disparities include differences in lifestyle, environment, genetics, and tumor biology. As we strive to personalize cancer therapy, it will...
Gespeichert in:
Veröffentlicht in: | Clinical pharmacology and therapeutics 2014-04, Vol.95 (4), p.403-412 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Racial and ethnic disparities in the pathogenesis of common malignancies and outcomes from treatment remain a major health concern. Factors attributed to these disparities include differences in lifestyle, environment, genetics, and tumor biology. As we strive to personalize cancer therapy, it will be imperative that we understand the relative contributions of each factor so that we may apply this knowledge in choosing the best treatment for each individual, regardless of his or her racial or ethnic heritage.
Clinical Pharmacology & Therapeutics (2014); 95 4, 403–412. doi:10.1038/clpt.2014.5 |
---|---|
ISSN: | 0009-9236 1532-6535 |
DOI: | 10.1038/clpt.2014.5 |